Amgen patent case revived by federal judge

A federal appeals court revived a bid by Amgen Inc. to have a U.S. trade agency block Roche Holding AG from importing and selling anemia treatments in the U.S. that would compete with Amgen’s biggest drugs. The U.S. Court of Appeals for the Federal Circuit last week reversed an International Trade Commission judge’s ruling that…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -